All Baxter articles
-
BusinessHurricane damage squeezes supply chains
Industry and government working to minimise impact of shortages of olefin feedstocks and medical products
-
-
Business
Baxter aims to divide and conquer
Firm will split off its biopharmaceuticals business from medical products
-
Business
Baxter to pay $4bn for dialysis firm
Gambro makes products for hemodialysis and continuous renal replacement therapy